1Vanderbilt UniversityInstitute
of Imaging Science, VanderbiltUniversityMedicalCenter,
Nashville, TN,
United States

The purpose of this presentation is to highlight the
potential for using phase contrast MR (PCMR) to quantify cerebral blood flow
to determine stroke risk in pediatric sickle cell disease patients.Because of the ramifications of
cerebrovascular accidents in this patient population, it is vital to
accurately assess cerebral blood flow, and phase contrast MR (PCMR) is
singularly well suited for this application.